Viewing StudyNCT00176488



Ignite Creation Date: 2024-05-05 @ 11:55 AM
Last Modification Date: 2024-10-26 @ 9:16 AM
Study NCT ID: NCT00176488
Status: TERMINATED
Last Update Posted: 2017-03-23
First Post: 2005-09-12

Brief Title: Epirubicin and Vinorelbine in Treating Patients With Stage II Stage III or Stage IV Breast Cancer
Sponsor: University of Medicine and Dentistry of New Jersey
Organization: Rutgers The State University of New Jersey

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
male breast cancer View
recurrent breast cancer View
stage II breast cancer View
stage IIIA breast cancer View
stage IIIB breast cancer View
stage IV breast cancer View